TRANSPOSE - TRANSfusion and transplantation: PrOtection and SElection of donors (Grant Agreement No. 738145) is a European Commission co-funded project, which will add to harmonising European donor selection and protection policies related to SoHO donations (Substances of Human Origin) whilst keeping adequate health & safety protection of the 5 millions patients in the EU who annually receive transfusions or transplantations of blood components, plasma-derived products, tissues & stem cells, germ cells for assisted reproductive technologies (ART) and organs The initiative will last 30 months (September 2017 - March 2020) and it involves 24 associated partners, including the project coordinator, and 12 collaborating partners representing 15 EU Member States and some European key organizations.
- The impact of TRANSPOSE will be threefold:
- Outcomes are expected to be of help in the revising process of related EU Directives.
- The set of guiding principles and Donor Selection & Protection Guidelines will facilitate EU member states to take a next step in implementing donor selection and protection policies in a consistent and clear-cut way to the benefit of both donors and recipients of SoHO.
- A standard Donor Health Questionnaire with carefully guided local/regional/national adjustments will become available, which can be used widely and will consequently enable comparisons of the prevalence of certain risks and risky behaviours throughout Europe.
Transpose project news
- February 21, 2020
- November 27, 2019
- August 8, 2019
- May 13, 2019
- April 29, 2019